| 0 |
ANTI KELL ANTIBODY TEST POSITIVE |
2 |
0.6667 |
| 1 |
RHESUS ANTIBODIES POSITIVE |
59 |
0.5315 |
| 2 |
BLOOD INCOMPATIBILITY HAEMOLYTIC ANAEMIA OF NEWBORN |
1 |
0.3333 |
| 3 |
ALLOIMMUNE HAEMOLYTIC ANAEMIA |
3 |
0.3000 |
| 4 |
GESTATIONAL ALLOIMMUNE LIVER DISEASE |
1 |
0.2500 |
| 5 |
PIK3CA RELATED OVERGROWTH SPECTRUM |
4 |
0.2500 |
| 6 |
COOMBS INDIRECT TEST NEGATIVE |
1 |
0.2000 |
| 7 |
RHESUS ANTIBODIES |
4 |
0.1739 |
| 8 |
FOETAL-MATERNAL HAEMORRHAGE |
8 |
0.1667 |
| 9 |
CONGENITAL HYPERINSULINAEMIC HYPOGLYCAEMIA |
2 |
0.1667 |
| 10 |
ISOIMMUNE HAEMOLYTIC DISEASE |
5 |
0.1316 |
| 11 |
STICKY PLATELET SYNDROME |
1 |
0.1111 |
| 12 |
PANCREATIC ISLETS HYPERPLASIA |
2 |
0.0952 |
| 13 |
COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
39 |
0.0850 |
| 14 |
CONTAMINATED PRODUCT ADMINISTERED |
5 |
0.0820 |
| 15 |
ANTIGLIADIN ANTIBODY POSITIVE |
2 |
0.0800 |
| 16 |
RHESUS HAEMOLYTIC DISEASE OF NEWBORN |
1 |
0.0769 |
| 17 |
MISLEADING LABORATORY TEST RESULT |
6 |
0.0723 |
| 18 |
PROTEIN URINE ABSENT |
1 |
0.0625 |
| 19 |
COOMBS INDIRECT TEST POSITIVE |
4 |
0.0541 |
| 20 |
RHESUS INCOMPATIBILITY |
6 |
0.0496 |
| 21 |
SYNOVIAL FLUID ANALYSIS |
4 |
0.0460 |
| 22 |
COOMBS DIRECT TEST POSITIVE |
13 |
0.0417 |
| 23 |
DIRECTIONAL DOPPLER FLOW TESTS ABNORMAL |
1 |
0.0385 |
| 24 |
OEDEMA NEONATAL |
2 |
0.0370 |
| 25 |
CONGENITAL LARYNGEAL STRIDOR |
1 |
0.0345 |
| 26 |
LYMPHOCYTOPENIA NEONATAL |
1 |
0.0333 |
| 27 |
DISSEMINATED INTRAVASCULAR COAGULATION IN NEWBORN |
1 |
0.0323 |
| 28 |
CONGENITAL INFECTION |
2 |
0.0323 |
| 29 |
MYCOPLASMA SEROLOGY POSITIVE |
1 |
0.0303 |
| 30 |
HIGH ARCHED PALATE |
5 |
0.0292 |
| 31 |
POLYMORPHIC ERUPTION OF PREGNANCY |
1 |
0.0286 |
| 32 |
SPONTANEOUS RUPTURE OF MEMBRANES |
1 |
0.0286 |
| 33 |
ANTI-HBC IGG ANTIBODY POSITIVE |
1 |
0.0278 |
| 34 |
ANTERIOR DISPLACED ANUS |
1 |
0.0263 |
| 35 |
CONGENITAL BOWING OF LONG BONES |
2 |
0.0247 |
| 36 |
LARYNGOMALACIA |
8 |
0.0239 |
| 37 |
FOETAL ANAEMIA |
3 |
0.0229 |
| 38 |
SENSORY PROCESSING SENSITIVITY |
1 |
0.0227 |
| 39 |
ALLOIMMUNISATION |
1 |
0.0217 |
| 40 |
CRANIAL SUTURES WIDENING |
3 |
0.0217 |
| 41 |
PROLONGED RUPTURE OF MEMBRANES |
1 |
0.0217 |
| 42 |
CAFE AU LAIT SPOTS |
2 |
0.0200 |
| 43 |
ERYTHROBLASTOSIS |
1 |
0.0200 |
| 44 |
FOETAL VASCULAR MALPERFUSION |
1 |
0.0196 |
| 45 |
APNOEA NEONATAL |
5 |
0.0193 |
| 46 |
HAEMORRHAGE FOETAL |
1 |
0.0189 |
| 47 |
POSTPARTUM SEPSIS |
1 |
0.0175 |
| 48 |
UMBILICAL CORD SHORT |
1 |
0.0175 |
| 49 |
GENITALIA EXTERNAL AMBIGUOUS |
3 |
0.0173 |
| 50 |
CEREBRAL HAEMORRHAGE FOETAL |
1 |
0.0164 |
| 51 |
LYMPHADENITIS |
39 |
0.0161 |
| 52 |
VAGINAL HAEMATOMA |
1 |
0.0156 |
| 53 |
FOETAL MALNUTRITION |
2 |
0.0155 |
| 54 |
CAPILLARY PERMEABILITY INCREASED |
1 |
0.0154 |
| 55 |
HAEMOLYTIC TRANSFUSION REACTION |
1 |
0.0154 |
| 56 |
MECONIUM ILEUS |
1 |
0.0152 |
| 57 |
SPHEROCYTIC ANAEMIA |
1 |
0.0145 |
| 58 |
CEREBRAL MICROHAEMORRHAGE |
6 |
0.0132 |
| 59 |
CAMPTODACTYLY CONGENITAL |
1 |
0.0132 |
| 60 |
GASTROINTESTINAL TOXICITY |
63 |
0.0131 |
| 61 |
ANTI-ERYTHROCYTE ANTIBODY POSITIVE |
1 |
0.0122 |
| 62 |
THROMBOCYTOPENIA NEONATAL |
5 |
0.0119 |
| 63 |
OBSTRUCTED LABOUR |
2 |
0.0118 |
| 64 |
CONGENITAL VESICOURETERIC REFLUX |
1 |
0.0116 |
| 65 |
FOETAL HEART RATE INCREASED |
1 |
0.0114 |
| 66 |
MECONIUM IN AMNIOTIC FLUID |
4 |
0.0114 |
| 67 |
HEPATITIS C ANTIBODY POSITIVE |
3 |
0.0111 |
| 68 |
VISUOSPATIAL DEFICIT |
1 |
0.0110 |
| 69 |
HYPERBILIRUBINAEMIA NEONATAL |
6 |
0.0103 |
| 70 |
DEFICIENCY OF BILE SECRETION |
1 |
0.0100 |
| 71 |
LEUKOERYTHROBLASTOSIS |
1 |
0.0100 |
| 72 |
PERSISTENT FOETAL CIRCULATION |
6 |
0.0098 |
| 73 |
MUSCLE TONE DISORDER |
3 |
0.0096 |
| 74 |
PULMONARY OEDEMA NEONATAL |
1 |
0.0096 |
| 75 |
BRADYCARDIA NEONATAL |
12 |
0.0095 |
| 76 |
RETICULOCYTOSIS |
2 |
0.0094 |
| 77 |
FOETAL MALPRESENTATION |
1 |
0.0093 |
| 78 |
C-REACTIVE PROTEIN ABNORMAL |
59 |
0.0092 |
| 79 |
TENOSYNOVITIS STENOSANS |
5 |
0.0090 |
| 80 |
PULMONARY TOXICITY |
63 |
0.0089 |
| 81 |
SYRINGE ISSUE |
155 |
0.0088 |
| 82 |
SYNOVIAL DISORDER |
4 |
0.0088 |
| 83 |
FOETAL HYPOKINESIA |
6 |
0.0086 |
| 84 |
RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION |
1 |
0.0085 |
| 85 |
NEONATAL RESPIRATORY DISTRESS |
8 |
0.0085 |
| 86 |
UTERINE MALPOSITION |
1 |
0.0085 |
| 87 |
NEONATAL ASPHYXIA |
6 |
0.0085 |
| 88 |
MIGRAINE WITH AURA |
23 |
0.0085 |
| 89 |
KIDNEY DUPLEX |
2 |
0.0083 |
| 90 |
MENINGOMYELOCELE |
5 |
0.0083 |
| 91 |
UMBILICAL CORD PROLAPSE |
1 |
0.0081 |
| 92 |
FORCEPS DELIVERY |
1 |
0.0077 |
| 93 |
PULMONARY ARTERY STENOSIS |
3 |
0.0077 |
| 94 |
CONGENITAL RENAL DISORDER |
2 |
0.0075 |
| 95 |
UTERINE HYPERTONUS |
2 |
0.0074 |
| 96 |
INTRAUTERINE INFECTION |
1 |
0.0074 |
| 97 |
LABOUR INDUCTION |
1 |
0.0074 |
| 98 |
COOMBS TEST POSITIVE |
2 |
0.0073 |
| 99 |
WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0071 |
| 100 |
NEWBORN PERSISTENT PULMONARY HYPERTENSION |
2 |
0.0071 |
| 101 |
MATERNAL EXPOSURE DURING DELIVERY |
7 |
0.0071 |
| 102 |
POST ABORTION HAEMORRHAGE |
1 |
0.0070 |
| 103 |
HYPOTHERMIA NEONATAL |
1 |
0.0070 |
| 104 |
PULMONARY VENOUS THROMBOSIS |
1 |
0.0067 |
| 105 |
CONGENITAL SCOLIOSIS |
1 |
0.0066 |
| 106 |
RETAINED PLACENTA OR MEMBRANES |
2 |
0.0066 |
| 107 |
SHOULDER DYSTOCIA |
1 |
0.0066 |
| 108 |
TRANSFUSION-RELATED ACUTE LUNG INJURY |
2 |
0.0065 |
| 109 |
MALABSORPTION FROM INJECTION SITE |
2 |
0.0065 |
| 110 |
AMNIOCENTESIS ABNORMAL |
1 |
0.0064 |
| 111 |
PLACENTA PRAEVIA |
5 |
0.0064 |
| 112 |
AMNIOTIC FLUID VOLUME INCREASED |
1 |
0.0063 |
| 113 |
AGITATION NEONATAL |
6 |
0.0063 |
| 114 |
HAEMOLYSIS |
47 |
0.0061 |
| 115 |
PATENT DUCTUS ARTERIOSUS |
24 |
0.0060 |
| 116 |
POLYDACTYLY |
7 |
0.0060 |
| 117 |
NEONATAL RESPIRATORY DEPRESSION |
2 |
0.0060 |
| 118 |
FOETAL MONITORING ABNORMAL |
1 |
0.0060 |
| 119 |
HAND-EYE COORDINATION IMPAIRED |
1 |
0.0059 |
| 120 |
CERVICAL INCOMPETENCE |
3 |
0.0059 |
| 121 |
SPEECH SOUND DISORDER |
1 |
0.0058 |
| 122 |
RETROPLACENTAL HAEMATOMA |
1 |
0.0058 |
| 123 |
FEEDING DISORDER NEONATAL |
6 |
0.0057 |
| 124 |
BLOOD CREATINE PHOSPHOKINASE MB INCREASED |
7 |
0.0055 |
| 125 |
CONGENITAL UMBILICAL HERNIA |
2 |
0.0054 |
| 126 |
DEVELOPMENTAL COORDINATION DISORDER |
1 |
0.0053 |
| 127 |
AMNIORRHOEA |
1 |
0.0053 |
| 128 |
PYELOCALIECTASIS |
5 |
0.0052 |
| 129 |
PRODUCT COUNTERFEIT |
9 |
0.0052 |
| 130 |
CONGENITAL ARTERIAL MALFORMATION |
1 |
0.0052 |
| 131 |
MOTOR DEVELOPMENTAL DELAY |
3 |
0.0052 |
| 132 |
CONGENITAL MEGAURETER |
1 |
0.0052 |
| 133 |
FAILED INDUCTION OF LABOUR |
1 |
0.0052 |
| 134 |
ENCOPRESIS |
1 |
0.0052 |
| 135 |
ANTIBODY TEST NEGATIVE |
1 |
0.0051 |
| 136 |
VESICOURETERIC REFLUX |
2 |
0.0049 |
| 137 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
6 |
0.0048 |
| 138 |
HYPOCAPNIA |
2 |
0.0048 |
| 139 |
ANEMBRYONIC GESTATION |
1 |
0.0048 |
| 140 |
CEREBRAL HAEMORRHAGE NEONATAL |
1 |
0.0047 |
| 141 |
MICROCEPHALY |
6 |
0.0047 |
| 142 |
GESTATIONAL DIABETES |
22 |
0.0046 |
| 143 |
MEDICATION MONITORING ERROR |
1 |
0.0046 |
| 144 |
DELIVERY |
3 |
0.0046 |
| 145 |
NODULAR RASH |
1 |
0.0045 |
| 146 |
PLACENTAL INFARCTION |
1 |
0.0045 |
| 147 |
POSTPARTUM HAEMORRHAGE |
6 |
0.0045 |
| 148 |
EAR MALFORMATION |
2 |
0.0043 |
| 149 |
RESPIRATORY DISORDER NEONATAL |
7 |
0.0043 |
| 150 |
CRANIOFACIAL DEFORMITY |
1 |
0.0043 |
| 151 |
WOLFF-PARKINSON-WHITE SYNDROME |
2 |
0.0042 |
| 152 |
SMALL FOR DATES BABY |
21 |
0.0042 |
| 153 |
JAUNDICE NEONATAL |
8 |
0.0042 |
| 154 |
BIOPSY SKIN ABNORMAL |
1 |
0.0042 |
| 155 |
TRANSFUSION-RELATED CIRCULATORY OVERLOAD |
1 |
0.0041 |
| 156 |
ENCEPHALOCELE |
1 |
0.0040 |
| 157 |
MENINGORRHAGIA |
1 |
0.0040 |
| 158 |
CYANOSIS CENTRAL |
1 |
0.0038 |
| 159 |
RED BLOOD CELL SEDIMENTATION RATE DECREASED |
1 |
0.0038 |
| 160 |
UTERINE ATONY |
1 |
0.0038 |
| 161 |
NEONATAL DISORDER |
6 |
0.0038 |
| 162 |
ANAL STENOSIS |
2 |
0.0038 |
| 163 |
FOETAL ARRHYTHMIA |
1 |
0.0037 |
| 164 |
INFANTILE APNOEA |
3 |
0.0037 |
| 165 |
CENTRAL NERVOUS SYSTEM NECROSIS |
1 |
0.0036 |
| 166 |
ANTIBODY TEST POSITIVE |
6 |
0.0036 |
| 167 |
FOETAL MACROSOMIA |
1 |
0.0036 |
| 168 |
PRODUCT INFORMATION CONTENT COMPLAINT |
1 |
0.0036 |
| 169 |
AUTOANTIBODY POSITIVE |
1 |
0.0036 |
| 170 |
TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT |
3 |
0.0035 |
| 171 |
SUSPECTED COUNTERFEIT PRODUCT |
14 |
0.0035 |
| 172 |
BURKHOLDERIA CEPACIA COMPLEX INFECTION |
1 |
0.0035 |
| 173 |
REGRESSIVE BEHAVIOUR |
1 |
0.0034 |
| 174 |
DYSMORPHISM |
8 |
0.0034 |
| 175 |
LEFT-TO-RIGHT CARDIAC SHUNT |
1 |
0.0034 |
| 176 |
TISSUE INFILTRATION |
1 |
0.0034 |
| 177 |
POLYCHROMASIA |
1 |
0.0033 |
| 178 |
JOINT LAXITY |
1 |
0.0033 |
| 179 |
HYDROPS FOETALIS |
2 |
0.0033 |
| 180 |
ATRIAL SEPTAL DEFECT |
27 |
0.0032 |
| 181 |
ALLERGY TO CHEMICALS |
4 |
0.0032 |
| 182 |
ANOMALY OF EXTERNAL EAR CONGENITAL |
1 |
0.0032 |
| 183 |
FOETAL CARDIAC DISORDER |
1 |
0.0032 |
| 184 |
RIGHT VENTRICULAR ENLARGEMENT |
1 |
0.0031 |
| 185 |
CYANOSIS NEONATAL |
2 |
0.0031 |
| 186 |
DOUBLE STRANDED DNA ANTIBODY POSITIVE |
1 |
0.0031 |
| 187 |
INTERMENSTRUAL BLEEDING |
17 |
0.0030 |
| 188 |
CENTRAL NERVOUS SYSTEM INFLAMMATION |
1 |
0.0030 |
| 189 |
JOINT INJURY |
64 |
0.0030 |
| 190 |
BACTERIAL PYELONEPHRITIS |
1 |
0.0030 |
| 191 |
RENAL VEIN THROMBOSIS |
2 |
0.0030 |
| 192 |
CONGENITAL HAND MALFORMATION |
2 |
0.0029 |
| 193 |
GAIT SPASTIC |
1 |
0.0029 |
| 194 |
UTERINE CONTRACTIONS DURING PREGNANCY |
3 |
0.0029 |
| 195 |
TALIPES |
9 |
0.0029 |
| 196 |
FIBROUS HISTIOCYTOMA |
1 |
0.0028 |
| 197 |
HEPATOTOXICITY |
63 |
0.0028 |
| 198 |
LYMPHOID TISSUE HYPERPLASIA |
1 |
0.0028 |
| 199 |
IMMUNISATION REACTION |
2 |
0.0028 |
| 200 |
WRONG PATIENT RECEIVED PRODUCT |
8 |
0.0027 |
| 201 |
ECLAMPSIA |
1 |
0.0027 |
| 202 |
PHIMOSIS |
2 |
0.0027 |
| 203 |
ADENOIDAL HYPERTROPHY |
1 |
0.0026 |
| 204 |
HYPEREMESIS GRAVIDARUM |
1 |
0.0026 |
| 205 |
MACROCEPHALY |
1 |
0.0026 |
| 206 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
9 |
0.0025 |
| 207 |
PULMONARY HYPOPLASIA |
2 |
0.0025 |
| 208 |
PULMONARY VALVE STENOSIS |
2 |
0.0025 |
| 209 |
SCLERITIS |
4 |
0.0025 |
| 210 |
BRAIN COMPRESSION |
1 |
0.0025 |
| 211 |
SEPSIS NEONATAL |
2 |
0.0025 |
| 212 |
PERIPHERAL CIRCULATORY FAILURE |
1 |
0.0024 |
| 213 |
DEVELOPMENTAL HIP DYSPLASIA |
2 |
0.0024 |
| 214 |
EXTRAVASCULAR HAEMOLYSIS |
1 |
0.0024 |
| 215 |
THREATENED LABOUR |
1 |
0.0023 |
| 216 |
TRANSFUSION REACTION |
2 |
0.0023 |
| 217 |
LACK OF SPONTANEOUS SPEECH |
1 |
0.0023 |
| 218 |
HEPATIC ENZYME DECREASED |
1 |
0.0022 |
| 219 |
CONGENITAL FOOT MALFORMATION |
1 |
0.0022 |
| 220 |
MANUFACTURING ISSUE |
1 |
0.0022 |
| 221 |
PULMONARY VASCULAR DISORDER |
1 |
0.0021 |
| 222 |
DRUG DISPENSED TO WRONG PATIENT |
2 |
0.0021 |
| 223 |
HAEMORRHAGE IN PREGNANCY |
3 |
0.0021 |
| 224 |
ANAEMIA NEONATAL |
1 |
0.0021 |
| 225 |
PLAGIOCEPHALY |
1 |
0.0020 |
| 226 |
MICROGNATHIA |
1 |
0.0020 |
| 227 |
JOINT STIFFNESS |
51 |
0.0019 |
| 228 |
FOETAL DEATH |
10 |
0.0019 |
| 229 |
HYPOSPADIAS |
4 |
0.0019 |
| 230 |
VENTRICULAR SEPTAL DEFECT |
11 |
0.0019 |
| 231 |
NO REACTION ON PREVIOUS EXPOSURE TO DRUG |
1 |
0.0019 |
| 232 |
JOINT CONTRACTURE |
2 |
0.0019 |
| 233 |
DEVICE ISSUE |
167 |
0.0019 |
| 234 |
EXECUTIVE DYSFUNCTION |
1 |
0.0018 |
| 235 |
HYPERTROPHY |
1 |
0.0018 |
| 236 |
MANUFACTURING PRODUCT SHIPPING ISSUE |
1 |
0.0018 |
| 237 |
RHEUMATOID NODULE |
5 |
0.0018 |
| 238 |
PLEURITIC PAIN |
5 |
0.0018 |
| 239 |
TYPE III IMMUNE COMPLEX MEDIATED REACTION |
1 |
0.0018 |
| 240 |
INTRAVASCULAR HAEMOLYSIS |
1 |
0.0018 |
| 241 |
HAEMOGLOBINURIA |
2 |
0.0018 |
| 242 |
CRYPTORCHISM |
2 |
0.0018 |
| 243 |
MEDICAL DEVICE SITE PAIN |
1 |
0.0018 |
| 244 |
KLEBSIELLA SEPSIS |
2 |
0.0018 |
| 245 |
DYSPRAXIA |
1 |
0.0018 |
| 246 |
BLOOD FIBRINOGEN DECREASED |
2 |
0.0018 |
| 247 |
CEREBRAL VENTRICLE DILATATION |
2 |
0.0017 |
| 248 |
LIMB REDUCTION DEFECT |
1 |
0.0017 |
| 249 |
DOSE CALCULATION ERROR |
1 |
0.0017 |
| 250 |
MATERNAL DRUGS AFFECTING FOETUS |
13 |
0.0017 |
| 251 |
PRODUCT CONTAMINATION MICROBIAL |
2 |
0.0017 |
| 252 |
FOETAL HEART RATE DECREASED |
1 |
0.0016 |
| 253 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
6 |
0.0016 |
| 254 |
DACRYOSTENOSIS ACQUIRED |
2 |
0.0015 |
| 255 |
GESTATIONAL HYPERTENSION |
2 |
0.0015 |
| 256 |
BLOOD IMMUNOGLOBULIN A DECREASED |
1 |
0.0015 |
| 257 |
HIV TEST POSITIVE |
1 |
0.0015 |
| 258 |
THEFT |
1 |
0.0015 |
| 259 |
TENOSYNOVITIS |
4 |
0.0014 |
| 260 |
DEATH NEONATAL |
2 |
0.0014 |
| 261 |
HAEMORRHAGIC CEREBRAL INFARCTION |
1 |
0.0014 |
| 262 |
MAST CELL ACTIVATION SYNDROME |
2 |
0.0014 |
| 263 |
FALSE NEGATIVE INVESTIGATION RESULT |
1 |
0.0014 |
| 264 |
FOETAL DISTRESS SYNDROME |
3 |
0.0014 |
| 265 |
ALCOHOL INTOLERANCE |
1 |
0.0014 |
| 266 |
ALPHA 1 FOETOPROTEIN INCREASED |
1 |
0.0014 |
| 267 |
CONGENITAL HYDRONEPHROSIS |
1 |
0.0014 |
| 268 |
ANTIBODY TEST ABNORMAL |
1 |
0.0014 |
| 269 |
THERAPY NON-RESPONDER |
62 |
0.0014 |
| 270 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
61 |
0.0014 |
| 271 |
CREPITATIONS |
4 |
0.0013 |
| 272 |
FOETAL EXPOSURE DURING PREGNANCY |
108 |
0.0013 |
| 273 |
FOETAL GROWTH RESTRICTION |
8 |
0.0013 |
| 274 |
UMBILICAL HERNIA |
6 |
0.0013 |
| 275 |
MATERNAL EXPOSURE DURING PREGNANCY |
114 |
0.0013 |
| 276 |
TRANSCRIPTION MEDICATION ERROR |
2 |
0.0013 |
| 277 |
NO ADVERSE EVENT |
231 |
0.0013 |
| 278 |
EXPOSURE DURING PREGNANCY |
79 |
0.0013 |
| 279 |
CUSHINGOID |
4 |
0.0012 |
| 280 |
RETICULOCYTE COUNT INCREASED |
1 |
0.0012 |
| 281 |
VULVOVAGINAL DRYNESS |
4 |
0.0012 |
| 282 |
HYPOGLYCAEMIA NEONATAL |
2 |
0.0012 |
| 283 |
ANTINUCLEAR ANTIBODY POSITIVE |
4 |
0.0012 |
| 284 |
NEONATAL HYPOXIA |
1 |
0.0012 |
| 285 |
SYSTEMIC INFECTION |
2 |
0.0012 |
| 286 |
BRADYCARDIA FOETAL |
1 |
0.0012 |
| 287 |
MUSCULOSKELETAL PAIN |
63 |
0.0012 |
| 288 |
VEIN RUPTURE |
2 |
0.0012 |
| 289 |
CEREBRAL VENOUS SINUS THROMBOSIS |
1 |
0.0012 |
| 290 |
GINGIVAL BLEEDING |
16 |
0.0012 |
| 291 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
8 |
0.0012 |
| 292 |
LIP PRURITUS |
1 |
0.0012 |
| 293 |
CRANIOSYNOSTOSIS |
1 |
0.0012 |
| 294 |
FOOD REFUSAL |
1 |
0.0011 |
| 295 |
LARGE FOR DATES BABY |
1 |
0.0011 |
| 296 |
CYTOMEGALOVIRUS TEST POSITIVE |
2 |
0.0011 |
| 297 |
PARVOVIRUS B19 INFECTION |
1 |
0.0011 |
| 298 |
ARTHROPATHY |
62 |
0.0011 |
| 299 |
HYPOGLYCAEMIC SEIZURE |
1 |
0.0011 |
| 300 |
SUSPECTED PRODUCT QUALITY ISSUE |
2 |
0.0011 |
| 301 |
PRURIGO |
1 |
0.0011 |
| 302 |
EXTENSOR PLANTAR RESPONSE |
1 |
0.0011 |
| 303 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0011 |
| 304 |
CEREBRAL PALSY |
1 |
0.0011 |
| 305 |
SPEECH DISORDER DEVELOPMENTAL |
3 |
0.0010 |
| 306 |
FALSE POSITIVE INVESTIGATION RESULT |
1 |
0.0010 |
| 307 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 308 |
POLYHYDRAMNIOS |
1 |
0.0010 |
| 309 |
NEOPLASM MALIGNANT |
64 |
0.0010 |
| 310 |
TREATMENT FAILURE |
79 |
0.0010 |
| 311 |
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY |
1 |
0.0009 |
| 312 |
PILOERECTION |
1 |
0.0009 |
| 313 |
PREMATURE DELIVERY |
14 |
0.0009 |
| 314 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
13 |
0.0009 |
| 315 |
SYNOVIAL CYST |
4 |
0.0009 |
| 316 |
HAEMANGIOMA |
2 |
0.0009 |
| 317 |
EXTRASYSTOLES |
6 |
0.0009 |
| 318 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
61 |
0.0009 |
| 319 |
HYPORESPONSIVE TO STIMULI |
1 |
0.0009 |
| 320 |
FOETAL ANTICONVULSANT SYNDROME |
1 |
0.0008 |
| 321 |
SKIN WEEPING |
3 |
0.0008 |
| 322 |
GANGRENE |
5 |
0.0008 |
| 323 |
STILLBIRTH |
4 |
0.0008 |
| 324 |
CONTRAINDICATED PRODUCT ADMINISTERED |
25 |
0.0008 |
| 325 |
FEBRILE CONVULSION |
1 |
0.0008 |
| 326 |
CARDIAC MURMUR |
7 |
0.0008 |
| 327 |
POST-ACUTE COVID-19 SYNDROME |
1 |
0.0008 |
| 328 |
BLOOD UREA DECREASED |
1 |
0.0008 |
| 329 |
NASAL PRURITUS |
1 |
0.0008 |
| 330 |
BREECH PRESENTATION |
1 |
0.0008 |
| 331 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
1 |
0.0008 |
| 332 |
TRISOMY 21 |
1 |
0.0008 |
| 333 |
APGAR SCORE LOW |
1 |
0.0008 |
| 334 |
DRUG CLEARANCE DECREASED |
1 |
0.0008 |
| 335 |
LOW BIRTH WEIGHT BABY |
6 |
0.0008 |
| 336 |
MUSCULOSKELETAL STIFFNESS |
65 |
0.0007 |
| 337 |
STENOTROPHOMONAS INFECTION |
1 |
0.0007 |
| 338 |
PREMATURE BABY |
22 |
0.0007 |
| 339 |
JOINT EFFUSION |
5 |
0.0007 |
| 340 |
ENCEPHALITIS |
5 |
0.0007 |
| 341 |
VIRAEMIA |
1 |
0.0007 |
| 342 |
PELVIC VENOUS THROMBOSIS |
1 |
0.0007 |
| 343 |
PRODUCT MONITORING ERROR |
1 |
0.0007 |
| 344 |
CAESAREAN SECTION |
8 |
0.0007 |
| 345 |
GROWTH RETARDATION |
2 |
0.0007 |
| 346 |
GASTRITIS HAEMORRHAGIC |
1 |
0.0007 |
| 347 |
BLOOD PRESSURE IMMEASURABLE |
1 |
0.0007 |
| 348 |
PREMATURE SEPARATION OF PLACENTA |
1 |
0.0006 |
| 349 |
HYPOTONIA NEONATAL |
1 |
0.0006 |
| 350 |
DRUG INTOLERANCE |
61 |
0.0006 |
| 351 |
PRE-ECLAMPSIA |
3 |
0.0006 |
| 352 |
LIMB DEFORMITY |
1 |
0.0006 |
| 353 |
INTRA-UTERINE DEATH |
1 |
0.0006 |
| 354 |
POSTURE ABNORMAL |
2 |
0.0006 |
| 355 |
INJECTION SITE ATROPHY |
1 |
0.0006 |
| 356 |
SEBORRHOEIC DERMATITIS |
1 |
0.0006 |
| 357 |
INFUSION RELATED REACTION |
40 |
0.0006 |
| 358 |
VENA CAVA THROMBOSIS |
1 |
0.0006 |
| 359 |
TROPONIN I INCREASED |
1 |
0.0006 |
| 360 |
OLIGOHYDRAMNIOS |
2 |
0.0006 |
| 361 |
ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE |
1 |
0.0006 |
| 362 |
PSEUDOMONAS INFECTION |
5 |
0.0006 |
| 363 |
PRODUCT CONTAINER SEAL ISSUE |
1 |
0.0006 |
| 364 |
HEPATIC ENZYME INCREASED |
39 |
0.0006 |
| 365 |
EXPIRED PRODUCT ADMINISTERED |
19 |
0.0006 |
| 366 |
SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS |
1 |
0.0006 |
| 367 |
WRONG DRUG ADMINISTERED |
5 |
0.0006 |
| 368 |
TUNNEL VISION |
1 |
0.0005 |
| 369 |
FLANK PAIN |
5 |
0.0005 |
| 370 |
HYPERCOAGULATION |
1 |
0.0005 |
| 371 |
CONJUNCTIVAL HAEMORRHAGE |
2 |
0.0005 |
| 372 |
INFLAMMATION |
27 |
0.0005 |
| 373 |
JOINT SWELLING |
63 |
0.0005 |
| 374 |
RHEUMATIC DISORDER |
1 |
0.0005 |
| 375 |
DIPLEGIA |
1 |
0.0005 |
| 376 |
EXPOSURE VIA BREAST MILK |
2 |
0.0005 |
| 377 |
ABORTION SPONTANEOUS |
20 |
0.0005 |
| 378 |
HYPERBILIRUBINAEMIA |
5 |
0.0005 |
| 379 |
ANAEMIA MACROCYTIC |
1 |
0.0005 |
| 380 |
EXOPHTHALMOS |
1 |
0.0005 |
| 381 |
LANGUAGE DISORDER |
1 |
0.0005 |
| 382 |
INFECTION |
66 |
0.0005 |
| 383 |
HAEMOLYTIC ANAEMIA |
4 |
0.0004 |
| 384 |
WRONG PRODUCT ADMINISTERED |
3 |
0.0004 |
| 385 |
GASTROINTESTINAL HYPOMOTILITY |
1 |
0.0004 |
| 386 |
HAEMOGLOBIN INCREASED |
2 |
0.0004 |
| 387 |
EYELID DISORDER |
1 |
0.0004 |
| 388 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 389 |
METHAEMOGLOBINAEMIA |
1 |
0.0004 |
| 390 |
DEFORMITY |
4 |
0.0004 |
| 391 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 392 |
YELLOW SKIN |
2 |
0.0004 |
| 393 |
PREMATURE RUPTURE OF MEMBRANES |
1 |
0.0004 |
| 394 |
HEPATITIS C |
5 |
0.0004 |
| 395 |
ATELECTASIS |
4 |
0.0004 |
| 396 |
EXPIRED DRUG ADMINISTERED |
2 |
0.0004 |
| 397 |
INTRAVENTRICULAR HAEMORRHAGE |
1 |
0.0004 |
| 398 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 399 |
BODY TEMPERATURE INCREASED |
8 |
0.0004 |
| 400 |
PERIORBITAL OEDEMA |
2 |
0.0004 |
| 401 |
TENDERNESS |
4 |
0.0004 |
| 402 |
FOLLICULITIS |
4 |
0.0004 |
| 403 |
HAND DEFORMITY |
5 |
0.0004 |
| 404 |
MIGRAINE |
36 |
0.0004 |
| 405 |
NASAL DISORDER |
1 |
0.0004 |
| 406 |
JOINT RANGE OF MOTION DECREASED |
5 |
0.0004 |
| 407 |
OVERWEIGHT |
2 |
0.0004 |
| 408 |
PHOTOPHOBIA |
7 |
0.0004 |
| 409 |
BLOOD BILIRUBIN INCREASED |
10 |
0.0004 |
| 410 |
TACHYPNOEA |
5 |
0.0004 |
| 411 |
AUTISM SPECTRUM DISORDER |
2 |
0.0004 |
| 412 |
RASH MACULO-PAPULAR |
8 |
0.0004 |
| 413 |
SERUM SICKNESS |
1 |
0.0004 |
| 414 |
LIVE BIRTH |
3 |
0.0004 |
| 415 |
REBOUND EFFECT |
4 |
0.0004 |
| 416 |
CEREBRAL THROMBOSIS |
1 |
0.0004 |
| 417 |
NEUROLOGICAL SYMPTOM |
2 |
0.0003 |
| 418 |
LIP PAIN |
1 |
0.0003 |
| 419 |
COMA SCALE ABNORMAL |
1 |
0.0003 |
| 420 |
ABORTION |
1 |
0.0003 |
| 421 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 422 |
FEELING OF BODY TEMPERATURE CHANGE |
2 |
0.0003 |
| 423 |
JAUNDICE |
9 |
0.0003 |
| 424 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 425 |
BURSITIS |
4 |
0.0003 |
| 426 |
INGUINAL HERNIA |
2 |
0.0003 |
| 427 |
EPSTEIN-BARR VIRUS INFECTION |
2 |
0.0003 |
| 428 |
INJECTION SITE HYPERSENSITIVITY |
1 |
0.0003 |
| 429 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 430 |
ABORTION INDUCED |
3 |
0.0003 |
| 431 |
CHILLS |
37 |
0.0003 |
| 432 |
ULCER |
5 |
0.0003 |
| 433 |
FACET JOINT SYNDROME |
1 |
0.0003 |
| 434 |
NODULE |
4 |
0.0003 |
| 435 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 436 |
PERICARDIAL EFFUSION |
7 |
0.0003 |
| 437 |
QUALITY OF LIFE DECREASED |
4 |
0.0003 |
| 438 |
PRODUCT ADMINISTRATION ERROR |
6 |
0.0003 |
| 439 |
DIABETIC RETINOPATHY |
1 |
0.0003 |
| 440 |
METRORRHAGIA |
5 |
0.0003 |
| 441 |
EYE MOVEMENT DISORDER |
2 |
0.0003 |
| 442 |
REGURGITATION |
1 |
0.0003 |
| 443 |
NEOPLASM PROGRESSION |
10 |
0.0003 |
| 444 |
PETECHIAE |
3 |
0.0003 |
| 445 |
NEUTROPENIA |
39 |
0.0003 |
| 446 |
DEVICE OCCLUSION |
4 |
0.0003 |
| 447 |
GLOSSITIS |
1 |
0.0003 |
| 448 |
ANAPHYLACTIC SHOCK |
7 |
0.0003 |
| 449 |
NEURODERMATITIS |
1 |
0.0003 |
| 450 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 451 |
DRUG EXPOSURE DURING PREGNANCY |
9 |
0.0003 |
| 452 |
RHEUMATOID ARTHRITIS |
30 |
0.0003 |
| 453 |
HAEMODYNAMIC INSTABILITY |
2 |
0.0003 |
| 454 |
CONGENITAL ANOMALY |
2 |
0.0003 |
| 455 |
WOUND SECRETION |
1 |
0.0003 |
| 456 |
CYANOSIS |
4 |
0.0003 |
| 457 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 458 |
PREGNANCY |
5 |
0.0002 |
| 459 |
TACHYCARDIA |
22 |
0.0002 |
| 460 |
ENURESIS |
1 |
0.0002 |
| 461 |
EXTRAVASATION |
1 |
0.0002 |
| 462 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 463 |
MUSCLE INJURY |
2 |
0.0002 |
| 464 |
CYTOMEGALOVIRUS INFECTION |
4 |
0.0002 |
| 465 |
ACCIDENTAL EXPOSURE |
1 |
0.0002 |
| 466 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 467 |
ANAPHYLACTIC REACTION |
13 |
0.0002 |
| 468 |
PAIN IN EXTREMITY |
69 |
0.0002 |
| 469 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
4 |
0.0002 |
| 470 |
TENSION HEADACHE |
1 |
0.0002 |
| 471 |
OCULAR ICTERUS |
1 |
0.0002 |
| 472 |
CHAPPED LIPS |
1 |
0.0002 |
| 473 |
MONOPLEGIA |
1 |
0.0002 |
| 474 |
HEAD DISCOMFORT |
4 |
0.0002 |
| 475 |
DEVICE BREAKAGE |
9 |
0.0002 |
| 476 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 477 |
PALLOR |
6 |
0.0002 |
| 478 |
C-REACTIVE PROTEIN INCREASED |
8 |
0.0002 |
| 479 |
EAR DISORDER |
1 |
0.0002 |
| 480 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 481 |
FEELING COLD |
6 |
0.0002 |
| 482 |
CONDITION AGGRAVATED |
65 |
0.0002 |
| 483 |
DISSEMINATED INTRAVASCULAR COAGULATION |
3 |
0.0002 |
| 484 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 485 |
FEELING JITTERY |
4 |
0.0002 |
| 486 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 487 |
FIBROMYALGIA |
5 |
0.0002 |
| 488 |
PRESYNCOPE |
5 |
0.0002 |
| 489 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 490 |
HAEMATOCRIT DECREASED |
4 |
0.0002 |
| 491 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 492 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 493 |
HYPOTHERMIA |
2 |
0.0002 |
| 494 |
ARTHRALGIA |
82 |
0.0002 |
| 495 |
OXYGEN SATURATION DECREASED |
11 |
0.0002 |
| 496 |
PHLEBITIS |
1 |
0.0002 |
| 497 |
EAR DISCOMFORT |
2 |
0.0002 |
| 498 |
PERIPHERAL SWELLING |
30 |
0.0002 |
| 499 |
HELICOBACTER INFECTION |
2 |
0.0002 |
| 500 |
TONSILLITIS |
1 |
0.0002 |
| 501 |
POOR QUALITY PRODUCT ADMINISTERED |
2 |
0.0002 |
| 502 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 503 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
3 |
0.0002 |
| 504 |
LEARNING DISABILITY |
1 |
0.0002 |
| 505 |
IMPAIRED WORK ABILITY |
4 |
0.0002 |
| 506 |
BEHAVIOUR DISORDER |
1 |
0.0002 |
| 507 |
NORMAL NEWBORN |
1 |
0.0002 |
| 508 |
PRODUCT DISPENSING ERROR |
4 |
0.0002 |
| 509 |
CONSTIPATION |
40 |
0.0002 |
| 510 |
TIC |
1 |
0.0002 |
| 511 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 512 |
RESPIRATORY DISTRESS |
5 |
0.0002 |
| 513 |
PLATELET COUNT DECREASED |
19 |
0.0002 |
| 514 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 515 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 516 |
MOUTH SWELLING |
1 |
0.0002 |
| 517 |
POST PROCEDURAL HAEMORRHAGE |
2 |
0.0002 |
| 518 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 519 |
HYPOXIA |
6 |
0.0002 |
| 520 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 521 |
HEPATITIS B |
1 |
0.0002 |
| 522 |
DRUG ADMINISTRATION ERROR |
5 |
0.0002 |
| 523 |
DRUG DIVERSION |
1 |
0.0002 |
| 524 |
MEDICATION ERROR |
9 |
0.0002 |
| 525 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 526 |
PRODUCT STORAGE ERROR |
14 |
0.0002 |
| 527 |
PHOTOPSIA |
1 |
0.0002 |
| 528 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 529 |
SKIN ULCER |
4 |
0.0002 |
| 530 |
INCOHERENT |
1 |
0.0002 |
| 531 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 532 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
1 |
0.0002 |
| 533 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 534 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 535 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 536 |
DYSGRAPHIA |
1 |
0.0002 |
| 537 |
MENINGITIS |
1 |
0.0001 |
| 538 |
THROMBOSIS |
12 |
0.0001 |
| 539 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 540 |
ECCHYMOSIS |
1 |
0.0001 |
| 541 |
DERMATITIS |
3 |
0.0001 |
| 542 |
THROMBOCYTOPENIA |
16 |
0.0001 |
| 543 |
FEAR OF INJECTION |
1 |
0.0001 |
| 544 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 545 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 546 |
SWELLING FACE |
9 |
0.0001 |
| 547 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 548 |
SENSITIVE SKIN |
1 |
0.0001 |
| 549 |
DUODENAL ULCER PERFORATION |
1 |
0.0001 |
| 550 |
PAROSMIA |
1 |
0.0001 |
| 551 |
ACIDOSIS |
1 |
0.0001 |
| 552 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 553 |
RASH PRURITIC |
7 |
0.0001 |
| 554 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 555 |
APNOEA |
1 |
0.0001 |
| 556 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 557 |
BONE DENSITY DECREASED |
4 |
0.0001 |
| 558 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 559 |
SCIATICA |
2 |
0.0001 |
| 560 |
MIOSIS |
1 |
0.0001 |
| 561 |
SENSORY LOSS |
1 |
0.0001 |
| 562 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 563 |
HYPERAESTHESIA |
1 |
0.0001 |
| 564 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 565 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 566 |
COAGULOPATHY |
2 |
0.0001 |
| 567 |
HAEMODIALYSIS |
1 |
0.0001 |
| 568 |
FACE OEDEMA |
2 |
0.0001 |
| 569 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 570 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 571 |
RASH GENERALISED |
3 |
0.0001 |
| 572 |
PYELONEPHRITIS |
1 |
0.0001 |
| 573 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 574 |
GROIN PAIN |
1 |
0.0001 |
| 575 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 576 |
PURPURA |
1 |
0.0001 |
| 577 |
LYMPHADENOPATHY |
4 |
0.0001 |
| 578 |
LIVER DISORDER |
5 |
0.0001 |
| 579 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 580 |
CEREBRAL HAEMORRHAGE |
4 |
0.0001 |
| 581 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 582 |
LEUKOCYTOSIS |
2 |
0.0001 |
| 583 |
SKIN LESION |
3 |
0.0001 |
| 584 |
UPPER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 585 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 586 |
EYE PAIN |
6 |
0.0001 |
| 587 |
PRODUCT DOSE OMISSION IN ERROR |
3 |
0.0001 |
| 588 |
CONVULSION |
6 |
0.0001 |
| 589 |
CHOLESTASIS |
2 |
0.0001 |
| 590 |
DRUG INEFFECTIVE |
137 |
0.0001 |
| 591 |
AFFECT LABILITY |
1 |
0.0001 |
| 592 |
INTERSTITIAL LUNG DISEASE |
5 |
0.0001 |
| 593 |
NEEDLE ISSUE |
3 |
0.0001 |
| 594 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 595 |
HYPERSENSITIVITY |
19 |
0.0001 |
| 596 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 597 |
LUNG DISORDER |
5 |
0.0001 |
| 598 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 599 |
HYPOTONIA |
1 |
0.0001 |
| 600 |
DRY EYE |
5 |
0.0001 |
| 601 |
BRAIN INJURY |
1 |
0.0001 |
| 602 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 603 |
PYREXIA |
34 |
0.0001 |
| 604 |
HAEMOGLOBIN DECREASED |
10 |
0.0001 |
| 605 |
INFLUENZA LIKE ILLNESS |
8 |
0.0001 |
| 606 |
SWELLING |
9 |
0.0001 |
| 607 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 608 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 609 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 610 |
RENAL PAIN |
1 |
0.0001 |
| 611 |
BREAST PAIN |
1 |
0.0001 |
| 612 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 613 |
IMPAIRED HEALING |
3 |
0.0001 |
| 614 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 615 |
LIP SWELLING |
3 |
0.0001 |
| 616 |
EYE PRURITUS |
3 |
0.0001 |
| 617 |
RASH PAPULAR |
2 |
0.0001 |
| 618 |
FISTULA |
1 |
0.0001 |
| 619 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 620 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 621 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 622 |
HAEMORRHAGE |
9 |
0.0001 |
| 623 |
WHEEZING |
5 |
0.0001 |
| 624 |
OCULAR HYPERAEMIA |
4 |
0.0001 |
| 625 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 626 |
CARDIOMEGALY |
1 |
0.0001 |
| 627 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 628 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 629 |
NAUSEA |
64 |
0.0001 |
| 630 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 631 |
HEART RATE INCREASED |
8 |
0.0001 |
| 632 |
HYPOTENSION |
16 |
0.0001 |
| 633 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 634 |
BRAIN OEDEMA |
1 |
0.0001 |
| 635 |
CARDIOVASCULAR DISORDER |
2 |
0.0001 |
| 636 |
TREMOR |
13 |
0.0001 |
| 637 |
CHEST DISCOMFORT |
8 |
0.0001 |
| 638 |
GENITAL HAEMORRHAGE |
1 |
0.0001 |
| 639 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 640 |
ARTHRITIS |
6 |
0.0001 |
| 641 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 642 |
BEDRIDDEN |
1 |
0.0001 |
| 643 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 644 |
DRY MOUTH |
6 |
0.0001 |
| 645 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 646 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 647 |
VISUAL IMPAIRMENT |
9 |
0.0001 |
| 648 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 649 |
APHONIA |
1 |
0.0001 |
| 650 |
NECK PAIN |
4 |
0.0001 |
| 651 |
LYMPHOPENIA |
1 |
0.0001 |
| 652 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 653 |
ANGINA PECTORIS |
2 |
0.0001 |
| 654 |
EYE IRRITATION |
4 |
0.0001 |
| 655 |
ACCIDENTAL UNDERDOSE |
1 |
0.0001 |
| 656 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 657 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 658 |
ANGIOEDEMA |
3 |
0.0001 |
| 659 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 660 |
LOWER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 661 |
URTICARIA |
11 |
0.0001 |
| 662 |
INJECTION SITE RASH |
2 |
0.0001 |
| 663 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 664 |
MYALGIA |
11 |
0.0001 |
| 665 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 666 |
RASH |
28 |
0.0001 |
| 667 |
BRAIN FOG |
1 |
0.0001 |
| 668 |
PNEUMOTHORAX |
1 |
0.0001 |
| 669 |
DIZZINESS |
31 |
0.0001 |
| 670 |
NIGHT SWEATS |
2 |
0.0001 |
| 671 |
HYPOGLYCAEMIA |
3 |
0.0001 |
| 672 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 673 |
BACK PAIN |
14 |
0.0001 |
| 674 |
VIRAL INFECTION |
2 |
0.0001 |
| 675 |
SYNCOPE |
6 |
0.0001 |
| 676 |
PERICARDITIS |
1 |
0.0001 |
| 677 |
DYSPNOEA |
33 |
0.0001 |
| 678 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 679 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 680 |
DELIRIUM |
2 |
0.0001 |
| 681 |
PRURITUS |
22 |
0.0001 |
| 682 |
RASH MACULAR |
2 |
0.0001 |
| 683 |
COLD SWEAT |
1 |
0.0001 |
| 684 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 685 |
THIRST |
1 |
0.0001 |
| 686 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
2 |
0.0001 |
| 687 |
DISTURBANCE IN ATTENTION |
3 |
0.0001 |
| 688 |
WHITE BLOOD CELL COUNT DECREASED |
6 |
0.0001 |
| 689 |
PELVIC PAIN |
1 |
0.0001 |
| 690 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 691 |
MUSCULAR WEAKNESS |
6 |
0.0001 |
| 692 |
MALAISE |
23 |
0.0001 |
| 693 |
ANAEMIA |
10 |
0.0001 |
| 694 |
INJECTION SITE SWELLING |
4 |
0.0001 |
| 695 |
LETHARGY |
3 |
0.0001 |
| 696 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 697 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 698 |
CHOKING |
1 |
0.0001 |
| 699 |
FEELING HOT |
3 |
0.0000 |
| 700 |
INJECTION SITE ERYTHEMA |
6 |
0.0000 |
| 701 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 702 |
MOUTH ULCERATION |
1 |
0.0000 |
| 703 |
EATING DISORDER |
1 |
0.0000 |
| 704 |
RETCHING |
1 |
0.0000 |
| 705 |
LOSS OF CONSCIOUSNESS |
6 |
0.0000 |
| 706 |
HYPOAESTHESIA |
7 |
0.0000 |
| 707 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 708 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 709 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 710 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 711 |
VAGINAL HAEMORRHAGE |
2 |
0.0000 |
| 712 |
INJECTION SITE PRURITUS |
3 |
0.0000 |
| 713 |
GLOSSODYNIA |
1 |
0.0000 |
| 714 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 715 |
PARAESTHESIA |
7 |
0.0000 |
| 716 |
CHROMATURIA |
1 |
0.0000 |
| 717 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 718 |
ERYTHEMA |
9 |
0.0000 |
| 719 |
TINNITUS |
2 |
0.0000 |
| 720 |
SHOCK |
1 |
0.0000 |
| 721 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 722 |
PALPITATIONS |
5 |
0.0000 |
| 723 |
DEVICE MALFUNCTION |
3 |
0.0000 |
| 724 |
ASTHENIA |
16 |
0.0000 |
| 725 |
SLEEP DISORDER |
3 |
0.0000 |
| 726 |
OFF LABEL USE |
37 |
0.0000 |
| 727 |
PULMONARY EMBOLISM |
4 |
0.0000 |
| 728 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 729 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 730 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 731 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 732 |
HAEMATEMESIS |
1 |
0.0000 |
| 733 |
FLUSHING |
4 |
0.0000 |
| 734 |
HYPOPHAGIA |
1 |
0.0000 |
| 735 |
SINUSITIS |
4 |
0.0000 |
| 736 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 737 |
ABDOMINAL PAIN |
9 |
0.0000 |
| 738 |
DIPLOPIA |
1 |
0.0000 |
| 739 |
DEAFNESS |
1 |
0.0000 |
| 740 |
ECZEMA |
2 |
0.0000 |
| 741 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 742 |
CHEST PAIN |
7 |
0.0000 |
| 743 |
DRY SKIN |
5 |
0.0000 |
| 744 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 745 |
PAIN OF SKIN |
1 |
0.0000 |
| 746 |
LIMB INJURY |
1 |
0.0000 |
| 747 |
HAEMOPTYSIS |
1 |
0.0000 |
| 748 |
BLISTER |
2 |
0.0000 |
| 749 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 750 |
DYSSTASIA |
1 |
0.0000 |
| 751 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 752 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 753 |
ASCITES |
1 |
0.0000 |
| 754 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 755 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 756 |
FEELING ABNORMAL |
8 |
0.0000 |
| 757 |
HEPATIC FAILURE |
1 |
0.0000 |
| 758 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 759 |
STOMATITIS |
2 |
0.0000 |
| 760 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 761 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 762 |
VERTIGO |
2 |
0.0000 |
| 763 |
DISCOMFORT |
2 |
0.0000 |
| 764 |
EPILEPSY |
1 |
0.0000 |
| 765 |
INJECTION SITE PAIN |
10 |
0.0000 |
| 766 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 767 |
VOMITING |
15 |
0.0000 |
| 768 |
HEADACHE |
20 |
0.0000 |
| 769 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 770 |
HEAD INJURY |
1 |
0.0000 |
| 771 |
GAIT DISTURBANCE |
6 |
0.0000 |
| 772 |
HYPERHIDROSIS |
4 |
0.0000 |
| 773 |
RHINORRHOEA |
2 |
0.0000 |
| 774 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
| 775 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 776 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 777 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 778 |
ANGER |
1 |
0.0000 |
| 779 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
0.0000 |
| 780 |
BURNING SENSATION |
2 |
0.0000 |
| 781 |
FATIGUE |
22 |
0.0000 |
| 782 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 783 |
PAIN |
17 |
0.0000 |
| 784 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 785 |
PANIC ATTACK |
1 |
0.0000 |
| 786 |
RESTLESSNESS |
1 |
0.0000 |
| 787 |
SEPSIS |
3 |
0.0000 |
| 788 |
DYSARTHRIA |
1 |
0.0000 |
| 789 |
INCORRECT DOSE ADMINISTERED |
6 |
0.0000 |
| 790 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 791 |
SEIZURE |
3 |
0.0000 |
| 792 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 793 |
DISORIENTATION |
1 |
0.0000 |
| 794 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 795 |
DYSKINESIA |
1 |
0.0000 |
| 796 |
CARDIAC ARREST |
2 |
0.0000 |
| 797 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 798 |
HYPERTENSION |
5 |
0.0000 |
| 799 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 800 |
BALANCE DISORDER |
2 |
0.0000 |
| 801 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 802 |
SEPTIC SHOCK |
1 |
0.0000 |
| 803 |
MENTAL DISORDER |
1 |
0.0000 |
| 804 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 805 |
VISION BLURRED |
3 |
0.0000 |
| 806 |
SKIN IRRITATION |
1 |
0.0000 |
| 807 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 808 |
ADVERSE EVENT |
2 |
0.0000 |
| 809 |
COUGH |
6 |
0.0000 |
| 810 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 811 |
AGGRESSION |
1 |
0.0000 |
| 812 |
SOMNOLENCE |
4 |
0.0000 |
| 813 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 814 |
NERVOUSNESS |
1 |
0.0000 |
| 815 |
SPEECH DISORDER |
1 |
0.0000 |
| 816 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 817 |
DIARRHOEA |
12 |
0.0000 |
| 818 |
OVERDOSE |
4 |
0.0000 |
| 819 |
PNEUMONIA |
6 |
0.0000 |
| 820 |
HYPONATRAEMIA |
1 |
0.0000 |
| 821 |
ASTHMA |
2 |
0.0000 |
| 822 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 823 |
DYSPHONIA |
1 |
0.0000 |
| 824 |
BONE PAIN |
1 |
0.0000 |
| 825 |
NASAL CONGESTION |
1 |
0.0000 |
| 826 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 827 |
IRRITABILITY |
1 |
0.0000 |
| 828 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 829 |
AMNESIA |
1 |
0.0000 |
| 830 |
PSORIASIS |
2 |
0.0000 |
| 831 |
RENAL FAILURE |
2 |
0.0000 |
| 832 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 833 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 834 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 835 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 836 |
UNDERDOSE |
1 |
0.0000 |
| 837 |
AGITATION |
1 |
0.0000 |
| 838 |
BRONCHITIS |
1 |
0.0000 |
| 839 |
DYSGEUSIA |
1 |
0.0000 |
| 840 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 841 |
ACNE |
1 |
0.0000 |
| 842 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 843 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 844 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 845 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 846 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 847 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 848 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 849 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 850 |
WEIGHT INCREASED |
2 |
0.0000 |
| 851 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 852 |
INSOMNIA |
2 |
0.0000 |
| 853 |
DEHYDRATION |
1 |
0.0000 |
| 854 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 855 |
WEIGHT DECREASED |
2 |
0.0000 |
| 856 |
ANXIETY |
2 |
0.0000 |
| 857 |
HOSPITALISATION |
1 |
0.0000 |
| 858 |
COVID-19 |
1 |
0.0000 |
| 859 |
MUSCLE SPASMS |
1 |
0.0000 |
| 860 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 861 |
DECREASED APPETITE |
1 |
0.0000 |
| 862 |
FALL |
1 |
0.0000 |
| 863 |
DEATH |
2 |
0.0000 |